Hemophilia Community Not 'Choosing A Side' In Hemlibra Litigation

Shire explains why it is seeking preliminary injunction against Genentech; National Hemophilia Foundation and Hemophilia Federation of America decline to take position on dispute.

RedBloodCellsOnWhite_1200x675

Shire PLC and Genentech Inc. have both gone to the hemophilia community to argue their position in litigation over Hemlibra (emicizumab-kxwh), but patient advocacy groups are declining to take sides in the dispute.

Shire subsidiary Baxalta Inc. filed a motion on Dec. 14 seeking a preliminary injunction to prevent Genentech, a unit...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet